- £138.16m
- £87.78m
- £82.34m
- 76
- 36
- 69
- 65
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 68.6 | 95.5 | 197 | 131 | 82.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 40.1 | 42.6 | 54.9 | 78.3 | 82.4 |
Operating Profit | 28.5 | 52.9 | 142 | 52.7 | -0.04 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 12.6 | 34.2 | 120 | 41.2 | -1.49 |
Provision for Income Taxes | |||||
Net Income After Taxes | 11.6 | 32.5 | 119 | 35.9 | -1.32 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 1.21 | 3.66 | 3.73 | 11 | -1.32 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.21 | 3.66 | 3.73 | 11 | -1.32 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | — | 0.03 | 0.03 | 0.089 | -0.011 |
Dividends per Share |